Zota Health Care Limited announced that its Board of Directors, in a meeting held on February 04, 2026, has approved amendments to the Code of Internal Procedures and Conduct for Regulating, Monitoring and Reporting of Trading by Insiders and the Code of Practices and Procedures for Fair Disclosure of Unpublished Price Sensitive Information. These amendments are in compliance with the SEBI (Prohibition of Insider Trading) (Amendment) Regulations, 2018. The company has provided the newly amended code for reference. The code aims to enhance governance standards and address changes in the organizational structure, reinforcing the company's commitment to fair disclosure and prevention of insider trading. The document details various definitions related to insider trading, including "Unpublished Price Sensitive Information" (UPSI), and outlines procedures for trading restrictions, pre-clearance of trades, and reporting requirements for transactions in securities. It also specifies penalties for contravention of the code.
